Author:
Peskar B. A.,Hesse W. H.,Rogatti W.,Rudofsky G.
Publisher
Springer Berlin Heidelberg
Reference18 articles.
1. Änggård E (1966) The biological activities of three metabolites of prostaglandin E1 Acta Physiol Scand 66: 509–510
2. Bothwell W, Verburg M, Wynalda M, Daniels EG, Fitzpatrick FA (1982) A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin and E2: an indirect index of their in vivo disposition and pharmacokinetics. J. Pharmacol Exp Ther 220: 229–235
3. Braun M, Ney P, Szymanski Ch, Bruch L, Schrbr K (1991) 13,14-dihydro-PGE1, a potent inhibitor of human platelet and neutrophil activation. Br J Pharmacol 102: 90 P
4. Cox JW, Andreadis VA, Bone RC, Maunder RJ, Pullen RH, Ursprung JJ, Vassar MJ (1988) Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continous intravenous infusion in patients with adult respiratory distress syndrome. Am Rev Respir Dis 137: 5–12
5. Diekmann JM, Jobke A, Peskar BA, Hertting G (1977) Angiotensin II-Induced contractions of rabbit splenic capsular strips and release of prostaglandins. Use of radioimmunoassays for prostaglandins E1 and E2. Naunyn-Schmiedebergs Arch Pharmacol 297: 177–183